The current valuation score of Neuropace Inc is 7.15, ranking 140 out of 199 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -19.98, which is -96.24% below the recent high of -0.75 and -47.16% above the recent low of -29.41.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.